MUDr. Markéta Bednaříková, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
| phone: | +420 532 23 8280, 3603 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 72
2024
-
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Gynecologic Oncology, year: 2024, volume: 185, edition: June 2024, DOI
-
Mapování lokalizace sentinelové uzliny u karcinomu endometria
Year: 2024, type: Conference abstract
-
MISMATCH-REPAIR DEFICIENCY IS ASSOCIATED WITH A HIGHER RISK OF RECURRENCE THAN NO SPECIFIC MOLECULAR PROFILE IN EARLY-STAGE ENDOMETRIAL CANCER
Year: 2024, type: Conference abstract
-
Operační léčba recidivujících gynekologických zhoubných nádorů
Ceska Gynekologie-Czech Gynaecology, year: 2024, volume: 89, edition: 4, DOI
-
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet, year: 2024, volume: 404, edition: 10460, DOI
-
Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer
Journal of Extracellular Vesicles, year: 2024, volume: 13, edition: 3, DOI
-
Systémová léčba karcinomu děložního hrdla
Onkogynekologie, edition: Vyd. 1., year: 2024, number of pages: 4 s.
2023
-
Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic
Year: 2023, type: Conference abstract
-
Molekulární testování karcinomu endometria - analýza prvních zkušeností z klinické praxe
Klinická onkologie, year: 2023, volume: 36, edition: 3, DOI
-
Novinky v systémové léčbě karcinomu endometria
Year: 2023, type: Article in Periodical (without peer review)